In Vitro Evaluation of Ferutinin Rich-Ferula communis L., ssp. glauca, Root Extract on Doxorubicin-Induced Cardiotoxicity: Antioxidant Properties and Cell Cycle Modulation
International Journal of Molecular Sciences · 13.08.2023 · 24 (16) · 12735
DOI: 10.3390/ijms241612735 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 13.08.2023. Verfasst von Roberta Macrì und 14 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacology Laboratory, Institute of Research for Food Safety and Health IRC-FSH, Department of Health Sciences, University Magna Graecia of Catanza…. Hauptthemen laut MEDLINE: Ferula, Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: PON-MIUR, POR Calabria FESR FSE 2014-2020, Italian Ministry of Research.
Abstract (Originalsprache)
The clinical use of anthracycline Doxorubicin as an antineoplastic drug in cancer therapy is limited by cardiotoxic effects that can lead to congestive heart failure. Recent studies have shown several promising activities of different species of the genus Ferula belonging to the Apiaceae Family. Ferula communis is the main source of Ferutinin—a bioactive compound isolated from many species of Ferula—studied both in vitro and in vivo because of their different effects, such as estrogenic, antioxidant, anti-inflammatory, and also antiproliferative and cytotoxic activity, performed in a dose-dependent and cell-dependent way. However, the potential protective role of Ferutinin in myocardium impairment, caused by chemotherapeutic drugs, still represents an unexplored field. The aim of this study was to test the effects of Ferutinin rich-Ferula communis L. root extract (FcFE) at different concentrations on H9C2 cells. Moreover, we evaluated its antioxidant properties in cardiomyocytes in order to explore new potential therapeutic activities never examined before in other experimental works. FcFE, at a concentration of 0.25 µM, in the H9C2 line, significantly reduced the ROS production induced by H2O2 (50 µM and 250 µM) and traced the cell mortality of the H9C2 co-treated with Ferutinin 0.25 µM and Doxorubicin (0.5 µM and 1 µM) to control levels. These results showed that FcFE could protect against Doxorubicin-induced cardiotoxicity. Further molecular characterization of this natural compound may open the way for testing FcFE at low concentrations in vivo and in clinical studies as an adjuvant in cancer therapy in association with anthracyclines to prevent side effects on heart cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pharmacology Laboratory, Institute of Research for Food Safety and Health IRC-FSH, Department of Health Sciences, University Magna Graecia of Catanzaro, 88100 Catanzaro, Italy.
- Department of Cardiology, IRCCS San Raffaele Pisana, 00166 Rome, Italy.
- Division of Cardiology, Fondazione Policlinico Tor Vergata, 00133 Rome, Italy.
- Pharmaceutical Biology Laboratory, Institute of Research for Food Safety and Health IRC-FSH, Department of Health Sciences, University Magna Graecia of Catanzaro, 88100 Catanzaro, Italy.
- Department of Health Sciences, University Magna Graecia of Catanzaro, 88100 Catanzaro, Italy.
- Veterinary Pharmacology Laboratory, Institute of Research for Food Safety and Health IRC-FSH, Department of Health Sciences, University Magna Graecia of Catanzaro, 88100 Catanzaro, Italy.
ORCID-Profile: Roberta Macrì, Rocco Mollace, Marta Greco, Daniela Foti, Luigi Tucci, Cristina Carresi, Ernesto Palma, Carolina Muscoli, Vincenzo Mollace
Förderung
- PON-MIUR
- POR Calabria FESR FSE 2014-2020
- Italian Ministry of Research
- POR Calabria FESR FSE 2014–2020
Zitieren
APA
Macrì, R., Bava, I., Scarano, F., Mollace, R., Musolino, V., Gliozzi, M., Greco, M., Foti, D., Tucci, L., Maiuolo, J., Carresi, C., Tavernese, A., Palma, E., Muscoli, C., & Mollace, V. (2023). In Vitro Evaluation of Ferutinin Rich-Ferula communis L., ssp. glauca, Root Extract on Doxorubicin-Induced Cardiotoxicity: Antioxidant Properties and Cell Cycle Modulation. International Journal of Molecular Sciences, 24(16), 12735. https://doi.org/10.3390/ijms241612735
Vancouver
Macrì R, Bava I, Scarano F, Mollace R, Musolino V, Gliozzi M, et al. In Vitro Evaluation of Ferutinin Rich-Ferula communis L., ssp. glauca, Root Extract on Doxorubicin-Induced Cardiotoxicity: Antioxidant Properties and Cell Cycle Modulation. International Journal of Molecular Sciences. 2023;24(16):12735. doi:10.3390/ijms241612735
BibTeX
@article{Macr2023,
author = {Macrì, Roberta and Bava, Irene and Scarano, Federica and Mollace, Rocco and Musolino, Vincenzo and Gliozzi, Micaela and Greco, Marta and Foti, Daniela and Tucci, Luigi and Maiuolo, Jessica and Carresi, Cristina and Tavernese, Annamaria and Palma, Ernesto and Muscoli, Carolina and Mollace, Vincenzo},
title = {In Vitro Evaluation of Ferutinin Rich-Ferula communis L., ssp. glauca, Root Extract on Doxorubicin-Induced Cardiotoxicity: Antioxidant Properties and Cell Cycle Modulation},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {16},
pages = {12735},
doi = {10.3390/ijms241612735}
}
EUVIMED